Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

 We are pleased to inform that in the matter of the Scheme of Amalgamation of Gufic Lifesciences Private Limited ('Transferor Company') with Gufic Biosciences Limited ('Transferee Company') and their respective shareholders and creditors ('Scheme'), the Hon'ble National Company Law Tribunal, Ahmedabad bench vide its order dated December 31, 2020 sanctioned the said Scheme, subject to the final order of the proceedings preferred by the Transferee Company before the Hon'ble National Company Law Tribunal, Mumbai bench. The said order is enclosed herewith, for your reference. We shall continue to update any further progress on the matter.
04-01-2021
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Closure of Trading Window

 Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time and the Company's Code of Conduct framed under the said provisions , the Trading Window for dealing in securities of the Company shall remain closed for all the Insiders (including Directors and Connected/ Designated Persons and their immediate relatives)from Friday, January 01, 2021 till 48 hours after the declaration of Un-Audited Financial Results of the Company for the quarter and nine month ended December 31, 2020.The date of meeting of the Board of Directors to consider and approve the Un-Audited Financial Result of the Company for the quarter and nine month ended December 31, 2020 will be informed in due course.
31-12-2020
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In terms of Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, please find enclosed herewith the newspaper advertisement for the Postal Ballot Notice, published on Saturday , December 19, 2020 in the newspapers Business Standard (in English Edition) and Mumbai Lakshwadeep (in Marathi Edition)
19-12-2020
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a copy of the Postal Ballot Notice dated December 01, 2020 along with Explanatory Statement seeking approval of the Members on Related Party Transactions by way of postal ballot only through remote voting by electronic means.
18-12-2020
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Statement Of Related Party Transactions For Half Year Ended September 30, 2020

 Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copy of disclosure pertaining to Related Party Transactions of the Company for the half year ended September 30, 2020.
10-12-2020
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Outcome Of The Board Meeting Held On December 01, 2020

 Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ('SEBI Listing regulations'), we would like to inform you that the Board of Directors of the Company at its Meeting held today i.e. Tuesday, December 01, 2020, inter alia has considered and approved the Postal Ballot notice for the following matter: Approval of related party transactions with Gufic Lifesciences Private Limited, a related party defined under the Companies Act, 2013 and SEBI Listing Regulations.
01-12-2020
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Grant Of Tigecycline Patent By Eurasian Patent Office

 We are pleased to inform you that the Company have been granted patent by the Eurasian Patent office (EAPO) for its invention of 'A FREEZE DRIED PARENTERAL COMPOSITION OF TIGECYCLINE AND PROCESS FOR PREPARATION THEREOF'. Kindly be informed that Tigecycline is a tetracycline antibiotic medication used for a number of bacterial infections and is used to treat certain serious infections including community acquired pneumonia (a lung infection that developed in a person who was not in the hospital), skin infections, and infections of the abdomen. Further, EAPO member States are Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyzstan, Russian Federation, Tajikistan and Turkmenistan. The said letter issued by the EAPO in its official language along with its English translation, is enclosed herewith, for your reference.
28-11-2020
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Gufic Biosciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
12-11-2020
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Change in Directorate

 Pursuant to Regulation 30 read with Part A of Schedule Ill to the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform that as recommended by the Nomination & Remuneration Committee, the Board of Directors at its meeting held today i.e. November 12, 2020, has appointed Mr. Dilip B. Ghosh (DIN: 00412406) as an Additional and Whole Time Director of the Company for a period of 5 (five) years w.e.f. November 12, 2020 till November 11, 2025, subject to the approval of shareholders and his brief profile is enclosed herewith. We hereby confirm that the director being appointed is not debarred from holding office as a Director of the Company, by virtue of any SEBI Order or any other such authority.
12-11-2020
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Outcome Of The Board Of Directors Meeting

 The Board of Directors of the Company at its meeting held on Thursday, November 12, 2020 inter alia transacted the following business matters: 1. The Board of Directors approved the Un-audited Financial Results of the Company for the quarter and half year ended September 30, 2020 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which are enclosed herewith along with the Limited Review Report received from the Statutory Auditor of the Company on the said Un-Audited Financial Results and the Management Report giving highlights for the quarter and half year ended September 30 , 2020 and future prospects. 2. The Board of Directors on the recommendation of the Nomination and Remuneration Committee, subject to the approval of shareholders at the ensuing general meeting, approved appointment of Mr. Dilip B. Ghosh as an Additional and Whole Time Director of the Company for a period of 5 (five) years with immediate effect
12-11-2020
Next Page
Close

Let's Open Free Demat Account